185 related articles for article (PubMed ID: 28849119)
1. Effect of RNA interference of the expression of HMGA2 on the proliferation and invasion ability of ACHN renal cell carcinoma cells.
Liu Y; Fu QZ; Pu L; Song LL; Wang YY; Liu J; Wang ZL; Wang ZM
Mol Med Rep; 2017 Oct; 16(4):5107-5112. PubMed ID: 28849119
[TBL] [Abstract][Full Text] [Related]
2. miR‑539 suppresses proliferation and induces apoptosis in renal cell carcinoma by targeting high mobility group A2.
Ye ZH; Gui DW
Mol Med Rep; 2018 Apr; 17(4):5611-5618. PubMed ID: 29436648
[TBL] [Abstract][Full Text] [Related]
3. Effects of HMGA2 on the epithelial-mesenchymal transition-related genes in ACHN renal cell carcinoma cells-derived xenografts in nude mice.
Liu Y; Lv G; Bai J; Song L; Ding E; Liu L; Tian Y; Chen Q; Li K; Liu X; Ding Y
BMC Cancer; 2022 Apr; 22(1):421. PubMed ID: 35439951
[TBL] [Abstract][Full Text] [Related]
4. The effects of RNA interference mediated VEGF gene silencing on biological behavior of renal cell carcinoma and transplanted renal tumor in nude mice.
Wang Q; Wang S; Sun SQ; Cheng ZH; Zhang Y; Chen G; Gu M; Yao HJ; Wang Z; Zhou J; Peng YB; Xu MX; Zhang K; Sun XW
Cancer Biomark; 2016; 16(1):1-9. PubMed ID: 26484606
[TBL] [Abstract][Full Text] [Related]
5. Effects of
Chen Q; Fu Q; Pu L; Liu X; Liu Y
J Int Med Res; 2022 Feb; 50(2):3000605221075511. PubMed ID: 35118889
[TBL] [Abstract][Full Text] [Related]
6. Alterations in enhancer of zeste homolog 2, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression are associated with ex vivo and in vitro bone metastasis in renal cell carcinoma.
Wang J; Ren Y; Guo X; Cheng H; Ye Y; Qi J; Yang C; You H
Mol Med Rep; 2015 May; 11(5):3585-92. PubMed ID: 25571919
[TBL] [Abstract][Full Text] [Related]
7. COP1 is downregulated in renal cell carcinoma (RCC) and inhibits the migration of RCC ACHN cells in vitro.
Ta L; Xuan C; Xing N; Zhu X
Mol Med Rep; 2016 Aug; 14(2):1371-8. PubMed ID: 27278120
[TBL] [Abstract][Full Text] [Related]
8. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
[TBL] [Abstract][Full Text] [Related]
9. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
Hong X; Yu JJ
Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
[TBL] [Abstract][Full Text] [Related]
10. HMGA2 facilitates epithelial-mesenchymal transition in renal cell carcinoma by regulating the TGF-β/Smad2 signaling pathway.
Kou B; Liu W; Tang X; Kou Q
Oncol Rep; 2018 Jan; 39(1):101-108. PubMed ID: 29138866
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-599 targets high-mobility group AT-hook 2 to inhibit cell proliferation and invasion in clear cell renal carcinoma.
Zhao H; Zhao H; Xia X; Liu X
Mol Med Rep; 2018 May; 17(5):7451-7459. PubMed ID: 29568870
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑24‑2 is associated with cell proliferation, invasion, migration and apoptosis in renal cell carcinoma.
Jin L; Li Y; Nie L; He T; Hu J; Liu J; Chen M; Shi M; Jiang Z; Gui Y; Yang S; Lai Y
Mol Med Rep; 2017 Dec; 16(6):9157-9164. PubMed ID: 28990105
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of long non-coding RNA differentiation antagonizing non-protein coding RNA inhibits the proliferation, migration and invasion and promotes apoptosis of renal cell carcinoma.
Jin L; Fu H; Quan J; Pan X; He T; Hu J; Li Y; Li H; Yang Y; Ye J; Zhang F; Ni L; Yang S; Lai Y
Mol Med Rep; 2017 Oct; 16(4):4463-4468. PubMed ID: 28765964
[TBL] [Abstract][Full Text] [Related]
14. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor.
Shoji S; Tang XY; Umemura S; Itoh J; Takekoshi S; Shima M; Usui Y; Nagata Y; Uchida T; Osamura RY; Terachi T
Eur Urol; 2009 Feb; 55(2):441-9. PubMed ID: 18395325
[TBL] [Abstract][Full Text] [Related]
15. [Effects of SIPL1 screened by suppression subtractive hybridization (SSH) on biological function and drug resistance of renal cell carcinoma cells].
Li CY; Yao AM; Chang XN; Guo YH; Xu R
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):897-903. PubMed ID: 24506958
[TBL] [Abstract][Full Text] [Related]
16. hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor.
Dong X; Kong C; Zhang Z; Liu X; Zhan B; Chen Z; Shi D
Urol Oncol; 2014 Aug; 32(6):885-92. PubMed ID: 24878177
[TBL] [Abstract][Full Text] [Related]
17. Effect of silencing of high mobility group A2 gene on gastric cancer MKN-45 cells.
Wei CH; Wei LX; Lai MY; Chen JZ; Mo XJ
World J Gastroenterol; 2013 Feb; 19(8):1239-46. PubMed ID: 23482887
[TBL] [Abstract][Full Text] [Related]
18. miR‑205 suppresses cell proliferation, invasion, and metastasis via regulation of the PTEN/AKT pathway in renal cell carcinoma.
Wang H; Chen B; Duan B; Zheng J; Wu X
Mol Med Rep; 2016 Oct; 14(4):3343-9. PubMed ID: 27498834
[TBL] [Abstract][Full Text] [Related]
19. CARD10 promotes the progression of renal cell carcinoma by regulating the NF‑κB signaling pathway.
Peng L; He K; Cao Z; Bi L; Yu D; Wang Q; Wang J
Mol Med Rep; 2020 Jan; 21(1):329-337. PubMed ID: 31939627
[TBL] [Abstract][Full Text] [Related]
20. LncRNA SNHG1 promotes renal cell carcinoma progression through regulation of HMGA2 via sponging miR-103a.
Ye ZH; Gui DW; Wang XY; Wang J; Fu JL
J Clin Lab Anal; 2022 Jun; 36(6):e24422. PubMed ID: 35466471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
